I appreciate the effort and depth of your analysis, especially the extra energy expended in trying to track down Gotama. I may be missing your point as regards keeping the stock price as low as possible for the benefit of the note-holders. Let me copy the terms of conversion from your post: "price equal to the greater of $0.15 or 90% of the average closing prices of the Company’s common stock." I'm therefore missing where there is any benefit to the note-holders in keeping the price under $.15, which is about ten times where the stock is holding these days.
FWIW, my take on the company and its stock is that it truly is a family business based on the line-up of the board/officers of the company, that Mr. Birnbaum who was the short-term CEO is an ethical person, and that that the pump-and-dump schemes were offensive to him. I would also believe that "the ultimate dumping" will take place as tax-loss selling in December, as the buyers at "pump-time" will take their medicine and the tax benefit of the their loss.
Yes, this is a real company with real store-locations, but it will need an intensive infusion of capital to keep going, which means that any future earnings stream is going to be very diluted.
News 
Market Data 
Discover 
